138 related articles for article (PubMed ID: 16775321)
1. Protective immunity against secondary poxvirus infection is dependent on antibody but not on CD4 or CD8 T-cell function.
Panchanathan V; Chaudhri G; Karupiah G
J Virol; 2006 Jul; 80(13):6333-8. PubMed ID: 16775321
[TBL] [Abstract][Full Text] [Related]
2. Ectromelia-encoded virulence factor C15 specifically inhibits antigen presentation to CD4+ T cells post peptide loading.
Forsyth KS; Roy NH; Peauroi E; DeHaven BC; Wold ED; Hersperger AR; Burkhardt JK; Eisenlohr LC
PLoS Pathog; 2020 Aug; 16(8):e1008685. PubMed ID: 32745153
[TBL] [Abstract][Full Text] [Related]
3. Memory CD8+ T cells are gatekeepers of the lymph node draining the site of viral infection.
Xu RH; Fang M; Klein-Szanto A; Sigal LJ
Proc Natl Acad Sci U S A; 2007 Jun; 104(26):10992-7. PubMed ID: 17578922
[TBL] [Abstract][Full Text] [Related]
4. T cell receptor sharing by cytotoxic T lymphocytes facilitates efficient virus control.
Chaudhri G; Quah BJ; Wang Y; Tan AH; Zhou J; Karupiah G; Parish CR
Proc Natl Acad Sci U S A; 2009 Sep; 106(35):14984-9. PubMed ID: 19706459
[TBL] [Abstract][Full Text] [Related]
5. Depression of protective mechanism during the early phase of a viral infection in tumor-bearing mice and prevention by PSK.
Tsuru S; Nomoto K; Taniguchi M; Fujisawa H; Zinnaka Y
Cancer Immunol Immunother; 1986; 22(2):114-8. PubMed ID: 2424596
[TBL] [Abstract][Full Text] [Related]
6. Poxvirus host cell entry.
Schmidt FI; Bleck CK; Mercer J
Curr Opin Virol; 2012 Feb; 2(1):20-7. PubMed ID: 22440962
[TBL] [Abstract][Full Text] [Related]
7. Correlates of protective immunity in poxvirus infection: where does antibody stand?
Panchanathan V; Chaudhri G; Karupiah G
Immunol Cell Biol; 2008 Jan; 86(1):80-6. PubMed ID: 17923850
[TBL] [Abstract][Full Text] [Related]
8. Monkeypox: Immune response, vaccination and preventive efforts.
Ophinni Y; Frediansyah A; Sirinam S; Megawati D; Stoian AM; Enitan SS; Akele RY; Sah R; Pongpirul K; Abdeen Z; Aghayeva S; Ikram A; Kebede Y; Wollina U; Subbaram K; Koyanagi A; Al Serouri A; Blaise Nguendo-Yongsi H; Edwards J; Sallam DE; Khader Y; Viveiros-Rosa SG; Memish ZA; Amir-Behghadami M; Vento S; Rademaker M; Sallam M
Narra J; 2022 Dec; 2(3):e90. PubMed ID: 38449905
[TBL] [Abstract][Full Text] [Related]
9. A Subunit Vaccine Candidate Composed of Mpox Virus A29L, M1R, A35R, and B6R Elicits Robust Immune Response in Mice.
Yang X; Yang X; Du S; Hu C; Yang X; Wang X; Hu X; Rcheulishvili N; Wang PG; Lin J
Vaccines (Basel); 2023 Aug; 11(9):. PubMed ID: 37766097
[TBL] [Abstract][Full Text] [Related]
10. Generation of recombinant mAbs to vaccinia virus displaying high affinity and potent neutralization.
Noy-Porat T; Tamir H; Alcalay R; Rosenfeld R; Epstein E; Cherry L; Achdout H; Erez N; Politi B; Yahalom-Ronen Y; Weiss S; Melamed S; Israely T; Mazor O; Paran N; Makdasi E
Microbiol Spectr; 2023 Sep; 11(5):e0159823. PubMed ID: 37737634
[TBL] [Abstract][Full Text] [Related]
11. Progress and prospects on vaccine development against monkeypox infection.
Saadh MJ; Ghadimkhani T; Soltani N; Abbassioun A; Daniel Cosme Pecho R; Taha A; Jwad Kazem T; Yasamineh S; Gholizadeh O
Microb Pathog; 2023 Jul; 180():106156. PubMed ID: 37201635
[TBL] [Abstract][Full Text] [Related]
12. Preventing monkeypox outbreaks: Focus on diagnosis, care, treatment, and vaccination.
Ghaseminia M
J Clin Transl Sci; 2023; 7(1):e60. PubMed ID: 37008622
[TBL] [Abstract][Full Text] [Related]
13. Genetic Variants and Protective Immunity against SARS-CoV-2.
Rabaan AA; Mutair AA; Aljeldah M; Shammari BRA; Sulaiman T; Alshukairi AN; Alfaresi M; Al-Jishi JM; Al Bati NA; Al-Mozaini MA; Bshabshe AA; Almatouq JA; Abuzaid AA; Alfaraj AH; Al-Adsani W; Alabdullah M; Alwarthan S; Alsalman F; Alwashmi ASS; Alhumaid S
Genes (Basel); 2022 Dec; 13(12):. PubMed ID: 36553622
[TBL] [Abstract][Full Text] [Related]
14. Neoadjuvant Intravenous Oncolytic Vaccinia Virus Therapy Promotes Anticancer Immunity in Patients.
Samson A; West EJ; Carmichael J; Scott KJ; Turnbull S; Kuszlewicz B; Dave RV; Peckham-Cooper A; Tidswell E; Kingston J; Johnpulle M; da Silva B; Jennings VA; Bendjama K; Stojkowitz N; Lusky M; Prasad KR; Toogood GJ; Auer R; Bell J; Twelves CJ; Harrington KJ; Vile RG; Pandha H; Errington-Mais F; Ralph C; Newton DJ; Anthoney A; Melcher AA; Collinson F
Cancer Immunol Res; 2022 Jun; 10(6):745-756. PubMed ID: 35439304
[TBL] [Abstract][Full Text] [Related]
15. Homologous and Heterologous Anti-COVID-19 Vaccination Does Not Induce New-Onset Formation of Autoantibodies Typically Accompanying Lupus Erythematodes, Rheumatoid Arthritis, Celiac Disease and Antiphospholipid Syndrome.
Thurm C; Reinhold A; Borucki K; Kahlfuss S; Feist E; Schreiber J; Reinhold D; Schraven B
Vaccines (Basel); 2022 Feb; 10(2):. PubMed ID: 35214790
[TBL] [Abstract][Full Text] [Related]
16. Proteomic assessment of humoral immune responses in smallpox vaccine recipients.
Kennedy RB; Ovsyannikova IG; Haralambieva IH; Grill DE; Poland GA
Vaccine; 2022 Jan; 40(5):789-797. PubMed ID: 34952760
[TBL] [Abstract][Full Text] [Related]
17. Predictive Markers of Immunogenicity and Efficacy for Human Vaccines.
Van Tilbeurgh M; Lemdani K; Beignon AS; Chapon C; Tchitchek N; Cheraitia L; Marcos Lopez E; Pascal Q; Le Grand R; Maisonnasse P; Manet C
Vaccines (Basel); 2021 Jun; 9(6):. PubMed ID: 34205932
[TBL] [Abstract][Full Text] [Related]
18. Correlates of Vaccine-Induced Protection against SARS-CoV-2.
Koch T; Mellinghoff SC; Shamsrizi P; Addo MM; Dahlke C
Vaccines (Basel); 2021 Mar; 9(3):. PubMed ID: 33801831
[TBL] [Abstract][Full Text] [Related]
19. COVID-19, varying genetic resistance to viral disease and immune tolerance checkpoints.
Goodnow CC
Immunol Cell Biol; 2021 Feb; 99(2):177-191. PubMed ID: 33113212
[TBL] [Abstract][Full Text] [Related]
20. Genes that Control Vaccinia Virus Immunogenicity.
Shchelkunov SN; Shchelkunova GA
Acta Naturae; 2020; 12(1):33-41. PubMed ID: 32477596
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
